Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome. - Wikidata - awgldk - TriplyDB

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.

http://www.wikidata.org/entity/Q44729880

about

Interventions for hirsutism (excluding laser and photoepilation therapy alone)Childhood obesity and its impact on the development of adolescent PCOS.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.Statins in the treatment of polycystic ovary syndrome.MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease.The optimal diet for women with polycystic ovary syndrome?PCOS.Epidermal growth factor receptor signaling is required for normal ovarian steroidogenesis and oocyte maturation Hirsutism: an evidence-based treatment update.Effect of Metformin and Flutamide on Anthropometric Indices and Laboratory Tests in Obese/Overweight PCOS Women under Hypocaloric Diet Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.The Effect of Flutamide on Ovulation Induction in PCOS Patients Enhanced ovarian folliclular development by metformin does not correlate with pregnancy rate: a randomized trial.Oocyte maturation: the coming of age of a germ cell.Ovarian steroids: the good, the bad, and the signals that raise them.Metformin and polycystic ovary syndrome.Polycystic ovary syndrome (PCOS): metformin State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome Polycystic ovary syndrome: chemical pharmacotherapy.Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.The effects of old, new and emerging medicines on metabolic aberrations in PCOS.Role of metformin in the management of polycystic ovary syndrome.Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome.Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.Comparison of Metformin and Simvastatin Administration in Women With Polycystic Ovary Syndrome Before Intra-Cytoplasmic Sperm Injection Cycle: A Prospective, Randomized, Clinical Trial Study Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome.Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women.Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome.Neuroendocrine dysfunction in PCOS: a critique of recent reviews.Idiopathic hirsutism and insulin resistance.Metabolic syndrome and polycystic ovary syndrome... and vice versa.Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.Obesity management in women with polycystic ovary syndrome.Relationship between serum cystatin C and polycystic ovary syndrome.Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.Evidence-based lifestyle and pharmacological management of infertility in women with polycystic ovary syndrome.

P2860

Q24186393-AD3887C4-F537-404D-8F60-51D0410EC07C Q30405587-960B6AA9-878C-43EC-951C-0BA9E8F99A66 Q33569169-84342623-B13E-4FD8-B921-34DE32EC7502 Q33587839-9599B446-23E7-4347-B6C0-3DCF84E76B58 Q33789151-37839873-F7E9-4A9D-81B4-6CBC11B13DBA Q33904576-9B87E941-0A76-4830-BB44-E0E2B8536B60 Q33989484-D610AFC6-CC88-45F4-82EB-C8E49924D64C Q34010581-C1A888C1-201F-4209-9875-01EC741EEF6A Q34132529-28C5C691-4346-4BD9-AF22-49BF30E2E3F0 Q34422575-6E73BB12-74D8-4196-928D-C734D48466B0 Q34490723-B6847544-A3E9-408D-9E07-45B9296E68B6 Q34598493-A04554F1-0299-4CF8-85F2-65F4F38100FF Q34661689-C8397745-F7D3-47EF-8244-C832CB98F38F Q34661716-C9F2B546-6D34-45C1-AE30-770446BD89A3 Q34693587-43AFBF0B-84E4-46AC-A478-BF70541E0683 Q34696198-AC79E259-332A-4AFF-A636-A739A987FC42 Q34746925-4E835A7D-8EB6-4806-8B4D-0AC36A0BA661 Q35222108-93DCF352-76B8-450F-9ABC-09041B956FCA Q35233754-9F7DF16A-FD7F-4B57-B39A-853272751395 Q35588552-B56049A3-BFFA-4227-A2D2-5FA4137B0C82 Q35597070-6D6D7606-C0F0-4396-846F-AAE6762A9265 Q35639510-9E23B543-F964-42CE-B33C-6E43E756D4F7 Q35763642-B1EDA945-F5AA-4EC0-AED6-626FBFE743A6 Q36328060-DB19BA96-C77D-4A0B-90E8-CB06A78481F6 Q36329913-D9828C76-2B59-4418-958B-9D9AD2D2A5D6 Q36352719-86FCCFC1-F15E-4A06-91AF-9448EEDEF7EF Q36366167-935C6D2C-1F7D-4402-93C6-5848E9B3D133 Q36446425-7AF9A6FD-87B3-4E76-A449-F2C6D4482133 Q36605428-6F5429D5-1572-42D9-8B7C-FA8881F598A1 Q36808872-9F174BA3-CF29-495D-B021-D1040482C492 Q36828547-0FA837EE-101B-46BC-980D-68E982D7CE8A Q36865817-3693C996-9985-4372-A989-CC6D9E37A352 Q36948002-01269D76-7066-453B-BA2A-BDE116CD0882 Q37280333-BA35C495-1EAE-413F-8E1A-122D5F5D0528 Q37494304-EF0FC6E9-5A86-4C9B-ABC1-E34AD70E32A7 Q37570577-6C5A0D69-DDAC-4F5B-A824-83800450E86E Q37608349-76DD1937-EDA9-401A-9AFD-D566D6D39BE1 Q37615466-2D768E26-CC3D-46A1-ADF2-36BC036A5680 Q37953819-6B42973E-288C-48B0-9644-120772CA7A87 Q38007200-2011843F-910D-4138-A753-8DFDD56D62A4

P2860

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.

http://www.wikidata.org/entity/Q44729880

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Effect of flutamide and metfor ...... ith polycystic ovary syndrome.

@en

Effect of flutamide and metfor ...... ith polycystic ovary syndrome.

@nl

type

label

Effect of flutamide and metfor ...... ith polycystic ovary syndrome.

@en

Effect of flutamide and metfor ...... ith polycystic ovary syndrome.

@nl

prefLabel

Effect of flutamide and metfor ...... ith polycystic ovary syndrome.

@en

Effect of flutamide and metfor ...... ith polycystic ovary syndrome.

@nl

P1433

Q44729880-99899B3F-942F-4040-B961-D79146DB09CF

P1476

Q44729880-C5F2898D-F1BA-4EBC-8D42-510724BA5318

P2093

Q44729880-3089B6C6-0953-443E-9A8C-18FD4928BE7A

Q44729880-325567C4-9D09-4E8F-99F7-20470F543789

Q44729880-40F64BEB-938F-409C-8F51-B27D5DD6285D

Q44729880-6DD4F99F-D77C-4A31-9E3D-279A78305157

Q44729880-6E6266FF-D04B-4D03-87C3-6BF2A3B5120E

Q44729880-87612068-5247-4380-AA1F-0B98FC95DB04

Q44729880-9673BF7F-BDB1-4056-B3CC-1A1A9CE0DEAF

P2860

Q44729880-029ED4D8-F90D-4D17-B25B-F39F77507D22

Q44729880-06583F16-E68B-4B4D-A619-0EEB0A32F33D

Q44729880-1F9DF0D7-908F-4F44-AAF0-CA482C3DD229

Q44729880-30681CD8-0054-4F58-BAD5-EEBD2DEF9A86

Q44729880-3258CED0-D44E-4EA2-9166-C4B0B6363C06

Q44729880-34E34DE2-BAEC-46ED-8291-2E660059BC58

Q44729880-739653CE-C3D6-4B17-91E0-EC423D86F5B2

Q44729880-7994E1B3-7629-4A21-9A72-B5B27A75EE27

Q44729880-869000AC-8A5B-4D4D-BE1B-B3B49CD70D14

Q44729880-8C33A676-67C4-4886-8030-7BEDF32733C7

P304

Q44729880-4D0B21CE-F565-40FE-83D1-DC26BD1C09C8

P31

Q44729880-F9F6264C-4431-4074-95B6-DFD612509F5F

P356

Q44729880-890DC5F7-9FA5-4B2A-9AE6-5D2E4A406029

P433

Q44729880-5EFCD752-7454-44BC-8671-525608CA277B

P478

Q44729880-BB238C3E-67F1-477F-AC9B-20704C84D7D7

P577

Q44729880-9F9E3685-84C1-40CC-8FC5-23D4FBDBF2EB

P698

Q44729880-227C1E21-954D-4739-B306-BCA07FA1BC85

P921

Q44729880-11F8A7C1-C169-48CC-B740-8B6BC457A36E

Q44729880-2B609CA9-A6C8-49FB-AC55-036886A58FAE

Q44729880-F21A2767-BF00-483D-94AF-C67BD0A6B62E

P356

J.1365-2265.2004.01973.X

P1433

Clinical Endocrinology

P1476

Effect of flutamide and metfor ...... ith polycystic ovary syndrome.

@en

P2093

Alessandra Gambineri

http://www.w3.org/2001/XMLSchema#string

Antonio Maria Morselli-Labate

http://www.w3.org/2001/XMLSchema#string

Carla Pelusi

http://www.w3.org/2001/XMLSchema#string

Mauro Cacciari

http://www.w3.org/2001/XMLSchema#string

Renato Pasquali

http://www.w3.org/2001/XMLSchema#string

Silvia Genghini

http://www.w3.org/2001/XMLSchema#string

Uberto Pagotto

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

Inhibition of rat testicular 17 alpha-hydroxylase and 17,20-lyase activities by anti-androgens (flutamide, hydroxyflutamide, RU23908, cyproterone acetate) in vitro

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy.

Should patients with polycystic ovarian syndrome be treated with metformin? A note of cautious optimism.

Hyperandrogenicity in women--a prediabetic condition?

Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.

The use of flutamide in the management of hirsutism.

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.

Repeatability characteristics of simple indices of insulin resistance: implications for research applications.

P304

241-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2265.2004.01973.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14725687

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome